ImmuCell Appoints Steven T. Rosgen and Bobbi Jo Brockmann to its Board of Directors
January 30, 2018 at 06:30 am EST
Share
ImmuCell Corporation announced that Mr. Steven T. Rosgen and Ms. Bobbi Jo Brockmann were appointed to its Board of Directors effective immediately. Mr. Rosgen, based in Calgary, Alberta, Canada, has more than 28 years of experience building brand strategies for products, services and organizations in a range of industries including working with leading global agricultural brands. Currently, he is President of Strategem Research Inc. Previously, he was a senior partner with Street Smart Strategic Planning. In addition to her appointment to the board, Ms. Brockmann will continue to serve the Company as Vice President of Sales and Marketing. She first joined ImmuCell as Director of Sales and Marketing in 2010. The Company’s Board of Directors is now comprised of four independent directors and three non-independent directors. All directors are subject to re-election by the Company’s stockholders at the 2018 Annual Meeting of Stockholders.
ImmuCell Corporation is an animal health company. The Company is engaged in the development, acquisition, manufacture, and sale of products that improve the health and productivity of dairy and beef cattle. It operates in two business segments: Scours and Mastitis. The Scours segment is engaged in manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows. The First Defense product line provides bovine antibodies that newborn calves need but are unable to produce on their own immediately after birth. Its product line extension, Tri-Shield First Defense, is the first calf-level, passive antibody product providing Immediate Immunity against each of the three causes of calf scours (E. coli, coronavirus, and rotavirus).
IMMUCELL CORPORATION 